The pharmaceutical industry faces a well-documented perfect storm: on the one hand, the patent cliff; the lack of new blockbusters and, on the other, economic pressure on pricing from markets with growing expectations and shrinking budgets. In the face of such pressure, traditional health economics models no longer seem appropriate and yet what do we have to replace them? The growing focus on 'value' and 'cost effectiveness' are evidence of new emerging thinking although, even here, with the shift from medicine as cure to medicine as palliative, as a treatment for chronic illness and with the growing emphasis on preventative approaches, the landscape is complex and challenging.
The Future of Health Economics offers a window into some of the most influential emerging issues in pharmacoeconomics; issues such as risk-sharing and alternative pricing models or the potential impact of radical new approaches such as personalized medicine; as well as exploring the changing role of government and regulators.
Ulf Staginnus and Olivier Ethgen, themselves two of the most well-regarded practitioners in this field, have brought together some leading-edge thinkers from industry and academia around the world to provide the industry, policy-makers, regulators, health practitioners and academics with the raw material for their future scenarios.
"synopsis" may belong to another edition of this title.
Olivier Ethgen is an Associate Professor of Health Economics at the Department of Public Health Sciences, School of Medicine, University of Liège, Belgium. He lectures in health economics (theory and applied modeling), decision sciences and pharmacoepidemiology.
Ulf Staginnus is a health economist and pharmaceutical executive with 20 years of international experience in the field of market access, pharmacoeconomics, pricing and reimbursement as well as health technology valuations within the biotechnology and pharmaceutical industry. Ulf is currently Vice President Value & Access, Region Europe with Shire in Zug, Switzerland.
"About this title" may belong to another edition of this title.
Shipping:
£ 7.37
From United Kingdom to U.S.A.
Shipping:
£ 15.49
From United Kingdom to U.S.A.
Seller: Reuseabook, Gloucester, GLOS, United Kingdom
Hardcover. Condition: Used; Like New. Dispatched, from the UK, within 48 hours of ordering. This book is in mint condition. Both the pages and the cover are completely intact, without zero sign of previous usage. Seller Inventory # CHL8941376
Quantity: 1 available
Seller: Chiron Media, Wallingford, United Kingdom
Hardcover. Condition: New. Seller Inventory # 6666-TNFPD-9781409445432
Quantity: 5 available
Seller: Biblios, Frankfurt am main, HESSE, Germany
Condition: New. Seller Inventory # 1850431532
Quantity: 4 available
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New. Seller Inventory # 25684325-n
Quantity: 5 available
Seller: GreatBookPricesUK, Castle Donington, DERBY, United Kingdom
Condition: New. Seller Inventory # 25684325-n
Quantity: 5 available
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New. pp. 200. Seller Inventory # 2650431526
Quantity: 4 available
Seller: moluna, Greven, Germany
Gebunden. Condition: New. Seller Inventory # 595723394
Quantity: Over 20 available
Seller: Revaluation Books, Exeter, United Kingdom
Hardcover. Condition: Brand New. new edition edition. 306 pages. 10.00x7.00x1.00 inches. In Stock. Seller Inventory # __1409445437
Quantity: 1 available
Seller: Majestic Books, Hounslow, United Kingdom
Condition: New. Print on Demand pp. 200. Seller Inventory # 58079737
Quantity: 4 available
Seller: GreatBookPricesUK, Castle Donington, DERBY, United Kingdom
Condition: As New. Unread book in perfect condition. Seller Inventory # 25684325
Quantity: 5 available